Fundación Fls De Lucha Contra El Sida, Las Enfermedades Infecciosas Y La Promoción De La Salud Y La Ciencia
Clinical trials sponsored by Fundación Fls De Lucha Contra El Sida, Las Enfermedades Infecciosas Y La Promoción De La Salud Y La Ciencia, explained in plain language.
-
Can a 10-day antiviral course protect kidney transplant patients from severe COVID?
Disease control Recruiting nowThis study tests whether giving the antiviral drug remdesivir for 10 days can prevent severe COVID-19 in kidney transplant recipients who have mild or no symptoms. About 15 adults will receive the drug starting just before their transplant. The goal is to see if this approach all…
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a cancer drug ease long COVID? new trial aims to find out
Symptom relief Recruiting nowThis Phase 2 trial tests whether the drug plitidepsin can improve overall health in 90 adults with moderate-to-severe long COVID symptoms. Participants receive either plitidepsin or a placebo intravenously over four 3-day cycles, with a 90-day follow-up. The study is double-blind…
Phase: PHASE2 • Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Monkeypox vaccine immune response under the microscope
Knowledge-focused Recruiting nowThis study looks at how the monkeypox vaccine (MVA-BN) sparks immune responses in 100 adults at high risk of infection, including those with and without HIV. Researchers will measure antibodies and other immune markers in blood samples taken after vaccination. The goal is to unde…
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Knowledge-focused
Last updated Jul 02, 2026 01:00 UTC